Critical size defect regeneration using PEG‐mediated BMP‐2 gene delivery and the use of cell occlusive barrier membranes – the osteopromotive principle revisited
- 31 July 2012
- journal article
- research article
- Published by Wiley in Clinical Oral Implants Research
- Vol. 24 (8) , 910-920
Abstract
Objective: The objective of this study was to investigate if osseous regeneration can be accelerated by involvement of periosteal tissue. Bone defect regeneration could be accelerated by the involvement of periosteal tissue if osteogenic cell signalling is maintained within the defect. It was questioned if local cell‐mediated BMP‐2 gene delivery makes a cell occlusive membrane dispensable during bone critical size defect regeneration.Methods: PEG matrix (degradation time 10 days) and PEG membrane (degradation time 120 days) were used in the pig calvarial model. Cylindrical (1 × 1 cm) critical size defects (CSD) (9 per animal; 20 animals) were filled with: (i) particulated autologous bone, covered with PEG membrane (group 1); (ii) HA/TCP, covered with PEG membrane (group 2); (iii) HA/TCP, mixed with PEG matrix (group 3); and (iv) HA/TCP mixed with BMP‐2‐transfected osteoblasts and PEG matrix (group 4). BMP‐2/4 gene transfer: liposomal in vitro transfection of BMP‐2/V5‐tag fusion‐protein. Quantitative histomorphometry (toluidine blue staining) after 2, 4 and 12 weeks assessed bone formation. Semiquantitative immunohistochemistry estimated the expression of BMP‐2, V5‐tag, Runx‐2 and Sox9.Results: PEG matrix embedded BMP‐2 expressing cells presented higher bone formation (P < 0.05) than HA/TCP + PEG matrix defect filling or PEG membrane covering (HA/TCP filling) after 12 weeks. Highest expression of BMP‐2, Runx‐2 and lowest expression of fibrous tissue marker Sox9 was seen in the BMP‐2 group.Conclusion: PEG matrix embedded BMP‐2 expressing cells are capable to maintain osteogenic signalling and to accelerate osseous defect regeneration in absence of a cell occlusive membrane.Keywords
This publication has 35 references indexed in Scilit:
- SOX9 determines RUNX2 transactivity by directing intracellular degradationJournal of Bone and Mineral Research, 2010
- SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossificationDevelopment, 2010
- Photo-Cross-Linked PDMSstar-PEG Hydrogels: Synthesis, Characterization, and Potential Application for Tissue Engineering ScaffoldsBiomacromolecules, 2010
- A randomized, controlled clinical trial to evaluate a new membrane for guided bone regeneration around dental implantsClinical Oral Implants Research, 2009
- Adenovirus BMP2-induced osteogenesis in combination with collagen carriersBiomaterials, 2007
- Endochondral Bone Formation from Hydrogel Carriers Loaded with BMP2-transduced CellsAnnals of Biomedical Engineering, 2007
- Effective Bone Engineering with Periosteum-derived CellsJournal of Dental Research, 2007
- Simple Carrier Matrix Modifications Can Enhance Delivery of Recombinant Human Bone Morphogenetic Protein-2 for Posterolateral Spine FusionSpine, 2003
- Protein delivery from materials formed by self-selective conjugate addition reactionsJournal of Controlled Release, 2001
- Interspecies Differences in Bone Composition, Density, and Quality: Potential Implications for in Vivo Bone ResearchEndocrinology, 1998